Skip to main content
icon for Encore Medical IPO Closing Marktkapitalisierung
Finanzen·Business

Encore Medical IPO Closing Marktkapitalisierung

icon for Encore Medical IPO Closing Marktkapitalisierung
Finanzen·Business

Encore Medical IPO Closing Marktkapitalisierung

Apr. 22

Mai 13

Mai 13

Mai 14

Apr. 22

Mai 13

Mai 13

Mai 14

Kein Börsengang vor Juni 2026 55%

50M–55M 10.0%

45–50 Mio. $ 7%

55 Mio.+ 4.5%

Polymarket

$23,667 Vol.

Kein Börsengang vor Juni 2026 55%

50M–55M 10.0%

45–50 Mio. $ 7%

55 Mio.+ 4.5%

Polymarket

$23,667 Vol.

<45M

$7,297 Vol.

3%

45–50 Mio. $

$2,594 Vol.

7%

50M–55M

$1,665 Vol.

9%

55 Mio.+

$3,001 Vol.

5%

Kein Börsengang vor Juni 2026

$9,109 Vol.

69%

This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.Trader consensus on Polymarket prices a 69% implied probability against an Encore Medical IPO before June 2026, driven by repeated delays beyond multiple rumored listing dates—including April 15, April 22, and early May 2026—despite S-1/A amendments through March and fixed terms announced December 2025 for a $15 million raise via 3 million shares at $5 each. This implies a $49 million fully diluted market cap, concentrating secondary odds in the 45M–55M bins at 16.7% combined, reflecting the cardiac implant developer's $2 million trailing revenue, ongoing FDA pivotal trial needs, and subdued medtech IPO appetite amid volatile small-cap markets. Key catalysts include potential pricing updates or roadshow announcements ahead of NYSE American debut under EMI.

This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
Volumen
$23,667
Enddatum
22. Apr. 2026
Markt eröffnet
Apr 3, 2026, 7:59 PM ET

Resolver

0x69c47De9D...
This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.Trader consensus on Polymarket prices a 69% implied probability against an Encore Medical IPO before June 2026, driven by repeated delays beyond multiple rumored listing dates—including April 15, April 22, and early May 2026—despite S-1/A amendments through March and fixed terms announced December 2025 for a $15 million raise via 3 million shares at $5 each. This implies a $49 million fully diluted market cap, concentrating secondary odds in the 45M–55M bins at 16.7% combined, reflecting the cardiac implant developer's $2 million trailing revenue, ongoing FDA pivotal trial needs, and subdued medtech IPO appetite amid volatile small-cap markets. Key catalysts include potential pricing updates or roadshow announcements ahead of NYSE American debut under EMI.

This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
Volumen
$23,667
Enddatum
22. Apr. 2026
Markt eröffnet
Apr 3, 2026, 7:59 PM ET

Resolver

0x69c47De9D...
This market will resolve based on Encore Medical’s market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 22 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Encore Medical IPO Closing Marktkapitalisierung" ist ein Prognosemarkt auf Polymarket mit 5 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „Kein Börsengang vor Juni 2026" mit 69%, gefolgt von „50M–55M" mit 9%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 69¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 69% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

Stand heute hat „Encore Medical IPO Closing Marktkapitalisierung" ein Gesamthandelsvolumen von $23.7K generiert, seit der Markt am Apr 4, 2026 gestartet wurde. Dieses Aktivitätsniveau spiegelt starkes Engagement der Polymarket-Community wider und stellt sicher, dass die aktuellen Quoten von einem breiten Pool an Marktteilnehmern geprägt werden. Sie können Live-Preisbewegungen verfolgen und direkt auf dieser Seite auf jedes Ergebnis handeln.

Um auf „Encore Medical IPO Closing Marktkapitalisierung" zu handeln, durchsuchen Sie die 5 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Encore Medical IPO Closing Marktkapitalisierung" ist „Kein Börsengang vor Juni 2026" mit 69%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 69% zuweist. Das nächstliegende Ergebnis ist „50M–55M" mit 9%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Encore Medical IPO Closing Marktkapitalisierung" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.